Annual Revenue
$155.00 K
-$219.00 K-58.56%
31 December 2023
Summary:
INmune Bio annual revenue is currently $155.00 thousand, with the most recent change of -$219.00 thousand (-58.56%) on 31 December 2023. During the last 3 years, it has risen by +$144.00 thousand (+1309.09%). INMB annual revenue is now -58.56% below its all-time high of $374.00 thousand, reached on 31 December 2022.INMB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
INmune Bio quarterly revenue is not available.INMB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
INmune Bio TTM revenue is not available.INMB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INMB Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.6% | - | - |
| 3 y3 years | +1309.1% | - | - |
| 5 y5 years | - | - | - |
INMB Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -58.6% | +1309.1% | ||||
| 5 y | 5 years | -58.6% | +1309.1% | ||||
| alltime | all time | -58.6% | +1309.1% |
INmune Bio Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $14.00 K(-50.0%) | $131.00 K(-15.5%) |
| Dec 2023 | $155.00 K(-58.6%) | $28.00 K(-34.9%) | $155.00 K(-30.8%) |
| Sept 2023 | - | $43.00 K(-6.5%) | $224.00 K(-19.7%) |
| June 2023 | - | $46.00 K(+21.1%) | $279.00 K(+12.0%) |
| Mar 2023 | - | $38.00 K(-60.8%) | $249.00 K(-33.4%) |
| Dec 2022 | $374.00 K | $97.00 K(-1.0%) | $374.00 K(-15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $98.00 K(+512.5%) | $440.00 K(+23.6%) |
| June 2022 | - | $16.00 K(-90.2%) | $356.00 K(+4.7%) |
| Mar 2022 | - | $163.00 K(0.0%) | $340.00 K(+87.8%) |
| Dec 2021 | $181.00 K(+1545.5%) | $163.00 K(+1064.3%) | $181.00 K(+524.1%) |
| Sept 2021 | - | $14.00 K(+250.0%) | $29.00 K(+93.3%) |
| Mar 2021 | - | $4000.00(-63.6%) | $15.00 K(+36.4%) |
| Dec 2020 | $11.00 K | $11.00 K | $11.00 K |
FAQ
- What is INmune Bio annual revenue?
- What is the all time high annual revenue for INmune Bio?
- What is INmune Bio annual revenue year-on-year change?
- What is the all time high quarterly revenue for INmune Bio?
- What is the all time high TTM revenue for INmune Bio?
What is INmune Bio annual revenue?
The current annual revenue of INMB is $155.00 K
What is the all time high annual revenue for INmune Bio?
INmune Bio all-time high annual revenue is $374.00 K
What is INmune Bio annual revenue year-on-year change?
Over the past year, INMB annual revenue has changed by -$219.00 K (-58.56%)
What is the all time high quarterly revenue for INmune Bio?
INmune Bio all-time high quarterly revenue is $163.00 K
What is the all time high TTM revenue for INmune Bio?
INmune Bio all-time high TTM revenue is $440.00 K